Kallikrein and kinin receptor genes

Pharmacology and Therapeutics

Volumn 88, Issue 1, 2000, Pages 77-89

  Mahabeer, Rajeshree ^a   Bhoola, Kanti D ^b  

^a UNIVERSITY OF NATAL   (South Africa)

^b DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

hKLK1, hKLK2, hKLK3 genes in cancer; Kinin receptor genes; Kinin receptor genes in cancer; Prostatic carcinoma; Tissue kallikrein genes

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR; KALLIKREIN; KININ; KININ RECEPTOR; KININ RECEPTOR ANTAGONIST; PROTEINASE; TISSUE KALLIKREIN; TISSUE KALLIKREIN INHIBITOR; UNCLASSIFIED DRUG;

BLOOD LEVEL; CANCER GROWTH; CELL PROLIFERATION; CONTROL SYSTEM; GENE INDUCTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; MOLECULAR BIOLOGY; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REVIEW;

ANIMAL; HUMAN; KALLIKREINS; KININS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CELL SURFACE; SUPPORT, NON-U.S. GOV'T;

EID: 0033802080     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00080-2     Document Type: Review

References (161)

1. The binding of tissue prokallikrein to isolated human neutrophils
2. Cloning and expression of human salivary-gland kallikrein in Escherichia coli
3. Kallikrein-related mRNAs of the rat submaxillary gland; nucleotide sequences of four distinct types including tonin
4. Tissue-specific expression of kallikrein-related genes in rat
5. Structure and genomic organisation of the human B1 receptor gene for kinins (BDKRB1)
6. Gene structure and chromosomal localisation of plasma kallikrein
7. Translocation of the neutrophil kinin moiety and changes in the regulation of kinin receptors in inflammation
8. Kinins-key mediators in inflammatory arthritis
9. Bioregulation of kinins; kallikreins, kininogens, and kininases
10. Over-expression and function characterisation of kinin receptors reveal subtype-specific phosphorylation
11. The recognition site for hepatic clearance of plasma kallikrein is on its heavy chain and is latent on prokallikrein
12. Synthesis of prekallikrein and metabolism of plasma kallikrein by perfused rat liver
13. Human plasma prekallikrein. Studies on its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate
14. Genomic DNA sequence, expression, and chromosomal localisation of the human B1 bradykinin receptor gene BDKRB1
15. Identification of tissue kallikrein in brain cell free translation product encoded by brain mRNA
16. Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatography
17. Tissue kallikrein in rat brain and pituitary; regional distribution and oestrogen induction in the anterior pituitary
18. Structural analysis of a rat renal kallikrein gene
19. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen
20. Cellular localisation of tissue kallikrein and kallistatin mRNAs in human kidney
21. Molecular cloning and characterisation of two rat renal kallikrein genes
22. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats
23. Extra-hepatic transcription of plasma prekallikrein gene in human and rat tissue
24. The glandular kallikrein family of enzymes; tissue-specific expression and hormonal regulation
25. The human kallikrein gene family; a diversity of expression and function
26. The molecular biology of the kallikreins and their roles in inflammation
27. Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers
28. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium
29. Kallikrein gene expression in human pituitary tissues
30. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
31. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages
32. Expression of tissue kallikrein in human kidney
33. Non-prostatic sources of prostate-specific antigen
34. Human prostate specific antigen (PSA) gene; structure and linkage to the kallikrein-like gene
35. Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma
36. Mouse glandular kallikrein genes; identification and characterisation of the genes encoding the epidermal growth factor binding proteins
37. Kallikreins, kinins and growth factor biosynthesis
38. Molecular aspects of kallikrein and kininogen in the maturing kidney
39. 2 receptors in the rat kidney; implications for segmental nephron maturation
40. Mouse glandular kallikrein genes
41. Structure and chromosomal localisation of the human renal kallikrein gene
42. Not more than three tissue kallikreins obtained from organs of the guinea-pig
43. Leukocyte tissue kallikrein; in an acute phase signal for inflammation
44. Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron
45. Kinins in the brain
46. Localisation of the bradykinin B2 receptor in the uterus, bladder and Madin-Darby canine kidney cells
47. Ein nues Kreislaufhornon und seine Wirkung
48. Zusammenhange zwischen Herzarbeit und Nierentatigkeit
49. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein
50. Characterisation of canine pancreas kallikrein cDNA
51. Immunological identification of rat tissue kallikrein cDNA and characterisation of the kallikrein gene family
52. Effect of prostate biopsy on the results of the PSA RT-PCR test
53. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer
54. Prostate-specific membrane antigen; current and future utility
55. Distribution of kinin B2 receptors in cultured cells, blood cells and tissue sections
56. The pharmacology and immunopharmacology of kinin receptors
57. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes
58. Assembly of contact phase factors on the surface of the human neutrophil membrane
59. cDNA for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes
60. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
61. Visualisation of tissue kallikrein in human breast carcinoma by two-dimensional western blotting and immunohistochemistry
62. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta
63. Expression of plasma prekallikrein mRNA in human nonhepatic tissues and cell lines suggests special local functions of the enzymes
64. Molecular pharmacology of kinin receptors
65. Cloning and pharmacological characterisation of a human bradykinin (BK-2) receptor
66. Cloning and pharmacological characterisation of bradykinin receptors
67. Human tissue kallikrein. II. Isolation and characterisation of human saliva kallikrein
68. 3H]Bradykinin receptor binding in mammalian tissue membranes
69. Molecular diversity of tissue kallikrein in human saliva
70. Molecular characterisation of cloned bradykinin B1 receptors from rat and human
71. Characterisation of a tissue kallikrein in human prolactin-secreting adenomas
72. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting adenomas
73. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone secreting adenomas
74. The human bradykinin B2 receptor gene; full length cDNA, genomic organisation and identification of the regulatory region
75. The coagulation-kinin pathway of human plasma
76. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2
77. Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils
78. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines
79. Expression of human glandular kallikrein, hK2, in mammalian cells
80. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein
81. Cloning, sequence analysis and expression of the gene encoding the mouse bradykinin B2 receptor
82. Structure and chromosomal localisation of gene (BDKRB2) encoding the bradykinin B2 receptor
83. Molecular biology of tissue kallikrein
84. Kallikrein-kinin in infection and cancer
85. Identification of prekallikrein and HMW-kininogen as a circulating complex in human plasma
86. 3H]Bradykinin receptor localisation in spinal cord and sensory ganglia-evidence for a role in primary afferent function
87. Kinin B1 receptors; a review
88. The B1 receptors for kinins
89. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease
90. Kallikreins and kinins. Molecular characteristics and cellular and tissue responses
91. Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides
92. Expression cloning of a rat B2 bradykinin receptor
93. Expression cloning of a human B1 bradykinin receptor
94. Kinins and endothelial control of vascular smooth muscle
95. hGK-1; a kallikrein gene expressed in human prostate
96. Human plasma kallikrein. Immunoreactivity and activity on natural and synthetic substrates
97. Kallikrein multigene families and the regulation of their expression
98. Androgen induction of a human prostate-specific kallikrein, hKLK2; characterisation of an androgen response element in the 5' promoter region of the gene
99. Immunoreactive BK1 receptors in human transbronchial tissue
100. Tissue kallikrein and kinins in renal disease
101. Cellular visualization of tissue prokallikrein in human neutrophils and myelocytes
102. Molecular cloning and characterisation of prostase, an androgen-regulated serine protease with prostate-restricted expression
103. Molecular cloning and expression of rat bradykinin B1
104. Bradykinin-B2 receptors in humans and rats; cDNA structures, gene structures, possible alternative splicing, and homology searching for subtypes
105. Molecular biology of the kallikrein-kinin system; from structure to function
106. Molecular structure and expression of rat bradykinin B2 receptor gene
107. Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells
108. Human bradykinin B2 receptor; nucleotide sequence analysis and assignment to chromosome 14
109. Localisation of human glandular kallikrein-1 gene to chromosome 19q13.3-13.4 by in situ hybridisation
110. Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue
111. Regional distribution of tissue kallikrein in the human brain
112. Visualisation of tissue kallikrein and kinin receptors in human astrocytomas
113. Kinin receptors are expressed in human astrocytic tumour cells
114. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma
115. Pharmacology of bradykinin and related kinins
116. Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas
117. The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19
118. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element
119. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species
120. Characterization of the human kallikrein locus
121. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA); two closely related, but distinct, kallikreins in the prostate
122. Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene
123. The kallikrein/kinin system and kinin antagonists in head trauma
124. Role of kinins in inflammatory responses. Prospects for drug therapy
125. Glandular kallikrein gene expression is selectively down-regulated by glucocorticoids in pancreatic AR42J cells
126. Renal bradykinin receptors; localisation, transduction pathways and molecular basis for a possible pathological role
127. Three alu repeated sequences associated with a human glandular kallikrein gene
128. Primary structure of a human glandular kallikrein gene
129. Kallikrein genes; cloning in man and expression in rat renal hypertension
130. Autoradiographic visualisation of B1 bradykinin receptors in porcine vascular tissues in the presence or absence of inflammation
131. Prostate-specific antigen expression is regulated by an upstream enhancer
132. The cDNA structure of rat plasma kallikrein
133. Mouse plasma kallikrein; cDNA structure, enzyme characterisation and comparison of protein and mRNA levels among species
134. Biochemical characteristics and recent knowledge on prostate-specific antigen
135. Localisation of bradykinin type II receptor mRNA in human endometrium
136. Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein
137. The kallikrein multigene family; specific processing of biologically active peptides
138. Cellular localisation of atrial natriuretic peptide and tissue kallikrein in the human hypothalamus
139. 2 receptor mRNAs in human kidney
140. Physical mapping of the rat tissue kallikrein family in two gene clusters by analysis of P1 bacteriophage clones
141. Localisation of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4
142. Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13
143. 2 bradykinin receptor gene maps to distal chromosome 12
144. Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer
145. Competitive antagonists of bradykinin
146. Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin
147. Molecular cloning and sequence analysis of rat bradykinin B2 receptor gene
148. Expression and cellular localisation of tissue kallikrein-kinin system in human adrenal gland
149. Der Kallikreingehalt des Harns, des Speichels und des Blutes bei Gesunden und Kranken
150. Uber die Wirkung des Kallikrein auf den isolierten Darm und uber eine neue darmkontrahierende Substanz
151. Isolierung und Struktur des Kallidin
152. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary gland
153. Localisation and expression of tissue kallikrein and kallistatin in human blood vessels
154. Identification of tissue kallikrein messenger RNA in human neutrophils
155. Genomic structure of the human bradykinin B1 receptor gene and preliminary characterisation of its regulatory regions
156. B2 bradykinin receptors in NG108-15 cells; cDNA cloning and functional expression
157. The new kallikrein-like gene, KLK-L2
158. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy
159. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease
160. Prostate-specific antigen in serum during the menstrual cycle